Krishnan Mahesh bought HALO
June 29, 2026 · Form 4 insider transaction
Krishnan Mahesh bought 7,304 shares of Halozyme Therapeutics, Inc. at $38.46 per share, a transaction worth $280.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,304
Price
$38.46
Total value
$280.9K
InsiderKrishnan Mahesh
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 29, 2026
Filing dateJune 30, 2026
Shares owned after21,766
OwnershipDirect
10b5-1 planNo
AmendedNo